Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Jul 30, 2026, 07:00 ET Basking Biosciences Announces Publication Showing BB-031 Restores Blood Flow in a Microfluidic Model of Acute Ischemic Stroke (AIS)
The study evaluated how BB-031 reopens vessels and compared its performance with the two approved fibrinolytics, alteplase (tPA) and tenecteplase (TNK). In the model, fully occlusive, platelet-rich clots were formed under arterial flow conditions, allowed to mature for up to six hours, and then treated.
More news about: Basking Biosciences Inc.
May 28, 2026, 16:01 ET Time Is Brain: Knowing Stroke Symptoms Can Save Lives
to his blood pressure, he has no lasting impacts from the stroke because his condition was noticed and treated quickly with Tenecteplase, also called TNK, a clot-busting drug."For every minute a stroke is left untreated, a million nerve cells in the brain die," said Dr. Nida Jamal, neurologist and
More news about: Mercy